요천추부 신경근통 시장 규모, 점유율 및 성장 분석 : 치료 유형별, 투여 경로별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Lumbosacral Radicular Pain Market size was valued at USD 0.9 Billion in 2024 and is poised to grow from USD 0.95 Billion in 2025 to USD 1.48 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global market for lumbosacral radicular pain is driven by a need for effective treatments targeting lower spine nerve-root compression, affecting approximately 5% of adults globally. The market includes pharmaceuticals, minimally invasive devices, and rehabilitation services, shifting focus from opioids due to concerns about misuse towards non-invasive solutions like steroid injections and radiofrequency ablation. The adoption of imaging-guided interventions, such as CT or ultrasound-guided procedures, significantly enhances treatment outcomes by improving accuracy and reducing recovery times, subsequently boosting procedural volumes and reimbursement rates within hospitals. This trend presents additional market growth opportunities for companies creating navigation software and disposable kits. Together, advancements in diagnostic techniques and favorable reimbursement policies are propelling significant market expansion on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lumbosacral Radicular Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lumbosacral Radicular Pain Market Segments Analysis

Global lumbosacral radicular pain market is segmented by treatment type, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented into pharmacological treatment, non-pharmacological treatment and interventional procedures. Based on route of administration, the market is segmented into oral, topical, injectable and implantable. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end user, the market is segmented into hospitals, specialty clinics, rehabilitation centers and homecare settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lumbosacral Radicular Pain Market

The increasing prevalence of degenerative spinal conditions among the aging population worldwide is significantly driving the demand for the Global Lumbosacral Radicular Pain market. This demographic shift has led to a growing number of patients seeking effective treatment options for lumbosacral radicular pain, prompting healthcare providers to focus on advanced symptom management strategies. Consequently, there is a heightened need for diagnostic imaging, pharmacological therapies, and minimally invasive interventions. The ongoing research into age-related neuropathic processes fosters innovation in treatment approaches, contributing to a dynamic market landscape fueled by the rising pursuit of relief from chronic nerve pain.

Restraints in the Global Lumbosacral Radicular Pain Market

In the Global Lumbosacral Radicular Pain market, financial constraints significantly hinder the adoption of advanced medical technologies such as spinal endoscopy, navigation systems, and programmable neurostimulators. Many healthcare providers, especially in public hospitals and developing countries, face budgetary restrictions that force them to rely on traditional surgical methods instead of embracing innovative solutions. This reluctance to invest in cutting-edge technology stems from the need to minimize costs, resulting in a slower integration of effective treatments despite a growing physician interest in less invasive options. Consequently, healthcare administrators must carefully evaluate the return on investment before allocating resources to new technological advancements.

Market Trends of the Global Lumbosacral Radicular Pain Market

The Global Lumbosacral Radicular Pain market is experiencing a notable shift towards the adoption of minimally invasive surgical techniques, driven by the increasing recognition of their advantages, such as reduced operative time, fewer complications, and expedited recovery periods for patients. This trend is propelling medical centers to invest in advanced imaging technologies and specialized training, enabling wider implementation of procedures like microdiscectomy and endoscopic decompression. As these techniques become more prevalent, they enhance accessibility in regional care facilities, empower healthcare providers to distinguish themselves from competitors, and address patient demand for less painful treatment options, ultimately creating new growth opportunities within the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Lumbosacral Radicular Pain Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological Treatment
  • Physical Therapy
  • Chiropractic Care
  • Acupuncture
• Non-Pharmacological Treatment
• Interventional Procedures
  • Epidural Steroid Injections
  • Nerve Blocks
  • Spinal Cord Stimulation
  • Surgical Intervention

Global Lumbosacral Radicular Pain Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical
• Injectable
• Implantable

Global Lumbosacral Radicular Pain Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Lumbosacral Radicular Pain Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Rehabilitation Centers
• Homecare Settings

Global Lumbosacral Radicular Pain Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Distribution Channel, End User)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Neuromodulation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations